|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61P 5/48 | (2018.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61K 38/28 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61P 5/48 | (2006.01) |
| (11) | Patento numeris | 3821905 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20208962.9 |
| Europos patento paraiškos padavimo data | 2017-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-05-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 16204688 | 2016-12-16 | EP |
| (72) |
NORRMAN, Mathias , DK
HOSTRUP, Susanne , DK
STEENSGAARD, Dorte Bjerre , DK
STRAUSS, Holger Martin , DK
HANSEN, Rosa Rebecca Erritzøe , DK
HAVELUND, Svend , DK
SCHLEIN, Morten , DK
PEDERSEN, Jesper Søndergaard , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (54) | INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |
| INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |